Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
This registry is for people with Myotonic Dystrophy (DM) or Facioscapulohumeral Muscular Dystrophy (FSHD), or unaffected family members of someone with these conditions. It aims to connect you with researchers studying these inherited disorders, which cause progressive muscle weakness. By joining, you'll have the opportunity to participate in research focused on DM and FSHD. The main goal is to understand how your symptoms change over time, which will help scientists learn more about these diseases and share their findings with patients and healthcare providers. This registry is currently open for enrollment and plans to include 3000 participants.
- Study design
- This is an observational study, meaning researchers will collect information about your health over time without providing any specific treatment. It aims to enroll 3000 participants.
- What's involved
- You would complete an application packet, which includes a patient information form, a medical records release form, and an informed consent form. After enrolling, you would complete an annual update form to track changes in your symptoms.
- Compensation
- Not stated in the trial record.
- Follow-up
- You would complete an annual update form to help track how your symptoms change over time.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Johann Hamel, MD · PRINCIPAL_INVESTIGATOR · University of Rochester Medical Center, Department of Neurology
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Patient reported outcomesAnnual